Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Modafinil to Improve Fatiguability

for
Cancer-related Cognitive Difficulties,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05333250

Phase 1, Phase 2, Recruiting

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT07226427

Phase 1, Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07349537

Phase 1, Recruiting

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: Fairfax VA, Grand Rapids MI, St Louis MO, Houston TX,
Sponsor: FoRx Therapeutics AG

Sex: All

Age: 18+

Code: NCT07356453

Phase 1, Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

for
Solid Tumor (Excluding CNS), Liver Cell Carcinoma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 1 - 26

Code: NCT07148050

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

for
Advanced Solid Tumor
Location: Port Huron MI, Macomb MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute

Sex: All

Age: 18+

Code: NCT07098299

Phase 1, Recruiting

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

for
Cancer, Oncology
Location: Hilo HI, Honolulu HI, Lihue HI
Sponsor: University of Hawaii

Sex: All

Age: 18+

Code: NCT06237816

Recruiting

Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)

for
Cancer, Cancer Pain, Chronic Cancer Pain
Location: Washington D.C. DC, Durham NC
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18+

Code: NCT07318519

Recruiting

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Valhalla NY, Philadelphia PA, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase 3, Recruiting

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07232043

Recruiting

Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer

for
Ovarian Clear Cell Carcinoma, Metastatic Ovarian Cancer,
Location: Boston MA
Sponsor: Tufts Medical Center

Sex: Female

Age: 18+

Code: NCT07718854

Phase 2, Recruiting

Testing a WearabLE Artificial Intelligence-POwered Device For OPtimal DAily RaDiation Therapy Using Image Guidance

for
Pelvic Malignancies
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT06820385

Recruiting

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

for
Colorectal Cancer, Pancreatic Cancer,
Location: Boston MA, Fairfax VA, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07300150

Phase 1, Recruiting

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

for
Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor,
Location: Montreal, Toronto, Vancouver
Sponsor: Australian & New Zealand Children's Haematology/Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06208657

Phase 1, Phase 2, Recruiting

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

for
Selected Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Glen Burnie MD
Sponsor: SK Life Science, Inc.

Sex: All

Age: 18+

Code: NCT07812805

Phase 1, Recruiting

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors
Location: Lake Success NY, Fairfax VA, Nashville TN
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07730021

Phase 1, Phase 2, Recruiting

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Lake Mary FL, Louisville KY, Denver CO,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase 1, Phase 2, Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New York NY, Houston TX
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT07408258

Phase 1, Recruiting

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

for
Hematologic, Oncologic, Bone Marrow
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT07743476

Recruiting

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

for
Thrombosis, Cancer, Thrombosis, Deep Vein,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07372716

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial